SotaterceptReal World Observational Study of Sotatercept for Pulmonary Hypertension

Primary outcome measure

• EmPHasis10 Questionnaire [ Time Frame: Baseline, Year 1, Year 2, Year 3, Year 4, Year 5, Year 6, Year 7, Year 8, Year 9, Year 10 ]
• Number of pulmonary hypertension vasodilator medications taken by a subject [ Time Frame: Baseline, Year 10 ]
• Number of patients to have a change in dose of prostanoid medications [ Time Frame: Baseline, Year 10 ]
• Number of patient hospitalizations [ Time Frame: Baseline, Year 10 ]
• Number of patients to cease therapy sessions [ Time Frame: Baseline, Year 10 ]
• Number of patients to discontinue prostanoid therapy [ Time Frame: Baseline, Year 10 ]
• Number of patients with bleeding complications [ Time Frame: Baseline, Year 10 ]
• Number of patients to develop Skin telangiectasias [ Time Frame: Baseline, Year 10 ]
• Change in 6 min walk distance [ Time Frame: Baseline, Year 10 ]
• Number of patients to have a change in hemodynamics [ Time Frame: Baseline, Year 10 ]
• Change in Right Ventricular Systolic Pressure (RVSP) [ Time Frame: Baseline, Year 10 ]
• Right Ventricular Strain [ Time Frame: Baseline, Year 10 ]
• Change in Right Ventricle (RV) function [ Time Frame: Baseline, Year 10 ]
• Change in capacitance [ Time Frame: Baseline, Year 10 ]
• Change in tricuspid regurgitation [ Time Frame: Baseline, Year 10 ]
• Change in Stroke Volume (SV) [ Time Frame: Baseline, Year 10 ]
• Change in Pulse Pressure (PP) [ Time Frame: Baseline, Year 10 ]
• Change in functional class [ Time Frame: Baseline, Year 10 ]
• Number of patients to survive without receiving a transplant [ Time Frame: Baseline, Year 10 ]